Azelaic acid
Pre-clinicalCompleted 0 watching 0 views this week๐ค Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rosacea
Conditions
Rosacea
Trial Timeline
Jul 1, 2010 โ Feb 1, 2011
NCT ID
NCT01631656About Azelaic acid
Azelaic acid is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01631656. Target conditions include Rosacea.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01631656 | Pre-clinical | Completed |
| NCT01038869 | Approved | Completed |
Competing Products
20 competing products in Rosacea